# A Study of TAS-205 for Duchenne Muscular Dystrophy

> **NCT02246478** · PHASE1 · COMPLETED · sponsor: **Taiho Pharmaceutical Co., Ltd.** · enrollment: 23 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** TAS-205
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02246478
- **Lead sponsor:** Taiho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-06
- **Final completion:** 2015-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02246478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02246478, "A Study of TAS-205 for Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02246478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*